Zobrazeno 1 - 10
of 12
pro vyhledávání: '"A F, Broomhead"'
Publikováno v:
European Journal of Haematology. 38:131-136
Patient records from January 1975 to December 1984 were analysed to assess the possible incidence of protein-bound vitamin B12 malabsorption. This condition is characterised by a low serum vitamin B12 level and a normal Schilling test but impaired ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697e02b60ec3dee603db53c3d9fb8ec5
https://doi.org/10.1111/j.1600-0609.1987.tb01150.x
https://doi.org/10.1111/j.1600-0609.1987.tb01150.x
Publikováno v:
European Journal of Cancer. 31:S182
Although oral morphine remains the opioid of choice for the management of moderate to severe cancer pain, controlled-release morphine fonnulations have only enabled dosing every 8 to 12 hours. Kadian™/Kapanol™ (K) is novel polymer-coated morphine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfee046fd59084d0a5aa3bcac6b5b9d4
https://doi.org/10.1016/0959-8049(95)96122-t
https://doi.org/10.1016/0959-8049(95)96122-t
Publikováno v:
Thrombosis and Haemostasis. 59:034-039
SummaryDDAVP was administered at 0.4 ug kg−1 by intravenous (i. v.) and subcutaneous (s.c.) routes to 6 healthy subjects in a double blind crossover study. Both study treatments were well tolerated. Flushing occurred after both treatments but was m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abad2f29a26fc087189d46b341fc7689
https://doi.org/10.1055/s-0038-1642561
https://doi.org/10.1055/s-0038-1642561
Autor:
Kenneth F. Bradstock, Alan F. Broomhead, A. Kabral, Margaret M. Prendergast, Wilbur G. Hughes, Michael C. Berndt, Kenneth Tiver
Publikováno v:
Transplantation. 41:565-571
The expression of Ia-like (class II MHC) antigens on canine hemopoietic cells was investigated using a cytotoxic murine monoclonal antibody, WM-2, reactive with dog Ia-like antigens. Another monoclonal antibody, WMD-1, reactive with canine Thy-1 anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8253b68c050f1cff419fdf6ab6c3f355
https://doi.org/10.1097/00007890-198605000-00003
https://doi.org/10.1097/00007890-198605000-00003
Publikováno v:
Pathology. 17:111-114
Summary Of the myeloproliferative disorders which develop in Down's syndrome, acute leukemia associated with trisomy 8 has distinct characteristics. It is non-lymphoblastic in type and has a preleukemic phase in which thrombocytopenia is a prominent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826d7ba280b1d89446257a60c76822b6
https://doi.org/10.3109/00313028509063737
https://doi.org/10.3109/00313028509063737
Publikováno v:
Journal of the Royal Society of Medicine. 79:47-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f678beed6bf02dd0231636c859ee8ccc
https://doi.org/10.1177/014107688607900116
https://doi.org/10.1177/014107688607900116
Autor:
M M, Prendergast, K F, Bradstock, A F, Broomhead, W G, Hughes, A, Kabral, M C, Berndt, K, Tiver
Publikováno v:
Transplantation. 41(5)
The expression of Ia-like (class II MHC) antigens on canine hemopoietic cells was investigated using a cytotoxic murine monoclonal antibody, WM-2, reactive with dog Ia-like antigens. Another monoclonal antibody, WMD-1, reactive with canine Thy-1 anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51fd330e6f06c778fda63e173e5f1e8b
https://pubmed.ncbi.nlm.nih.gov/2871645
https://pubmed.ncbi.nlm.nih.gov/2871645
Publikováno v:
Thrombosis and haemostasis. 59(1)
DDAVP was administered at 0.4 microgram kg-1 intravenous (i.v.) and subcutaneous (s.c.) routes to 6 healthy subjects in a double blind crossover study. Both study treatments were well tolerated. Flushing occurred after both treatments but was more pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c70621e6833fb8539ecc739121388d0
https://pubmed.ncbi.nlm.nih.gov/3129807
https://pubmed.ncbi.nlm.nih.gov/3129807
Autor:
N.M. Potter, J.H. Chesters, G.G. Thurlow, R. Jackson, A.D. Mackower, D.C. Gunn, I.G.C. Dryden, L.H. Leighton, J.E. Garside, F. Broomhead, G.R. Hall, G.A. Payne, I. Fells, A.J. Rogers, D.G. Skinner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8875f070a8fcbc832c93fc8a06f351f5
https://doi.org/10.1016/b978-0-408-01250-8.50007-6
https://doi.org/10.1016/b978-0-408-01250-8.50007-6
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
DDAVP is used effectively to induce a haemostatic response in certain types of haemophilia A and von Willebrands disease, but the accompanying increase in fibrinolytic activity is an unwanted effect. Here we have quantified the extent and time course
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d63dee820791c74e16823735ca29fa
https://doi.org/10.1055/s-0038-1644133
https://doi.org/10.1055/s-0038-1644133